晶緻生物｜病理實驗室

From Tissue to Insight

breast cancer

2026 年 4 月 12 日

Residual risk stratification of Taiwanese breast cancers following curative therapies with the extended concurrent genes signature
2026 年 4 月 12 日

Targeted Sequencing of Taiwanese Breast Cancer with Risk Stratification by the Concurrent Genes Signature: A Feasibility Study